Pure Global

IVD Cluster for Anemia: Ferritin, Transferrin - Vietnam Registration 240000688/PCBB-HN

Access comprehensive regulatory information for IVD Cluster for Anemia: Ferritin, Transferrin in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại B medical device is registered under number 240000688/PCBB-HN and manufactured by Beckman Coulter, Inc.. The authorized representative in Vietnam is CÔNG TY TNHH KỸ THUẬT NAM PHƯƠNG.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
240000688/PCBB-HN
Registration Details
Vietnam MOH Registration: 240000688/PCBB-HN
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

IVD Cluster for Anemia: Ferritin, Transferrin
VN: Cụm IVD Bệnh thiếu máu: Ferritin, Transferrin
Risk Class TTBYT Loại B

Registration Details

240000688/PCBB-HN

000.00.19.H26-240229-0018

Theo theo phụ lục

Theo phụ lục

Company Information

Theo theo phụ lục

Beckman Coulter, Inc.

Technical Details

1. Ferritin: Ferritin test is an in vitro diagnostic medical device used by medical specialists to quantify ferritin in human serum and plasma by the turbidimetric immunodetection method, on the Beckman Coulter AU/DxC AU automated analyzers. The measurement of ferritin is used in the diagnostic support of iron deficiency anemia and iron overload disorders. 2. Transferrin: Transferrin test is an in vitro diagnostic medical device used by medical specialists to quantify transferrin in human serum and plasma, on the Beckman Coulter AU/DxC AU automated analyzers. The measurement of transferrin is used in the diagnostic support of anemia and anemia due to iron transport deficiency.

Dates and Status

Mar 28, 2024